ATE518533T1 - Pharmazeutische zusammensetzung, die einen spezifischen aminopeptidase-a inhibitor enthält, insbesondere ec33, zur senkung des blutdrucks - Google Patents

Pharmazeutische zusammensetzung, die einen spezifischen aminopeptidase-a inhibitor enthält, insbesondere ec33, zur senkung des blutdrucks

Info

Publication number
ATE518533T1
ATE518533T1 AT99900531T AT99900531T ATE518533T1 AT E518533 T1 ATE518533 T1 AT E518533T1 AT 99900531 T AT99900531 T AT 99900531T AT 99900531 T AT99900531 T AT 99900531T AT E518533 T1 ATE518533 T1 AT E518533T1
Authority
AT
Austria
Prior art keywords
inhibitor
pharmaceutical composition
blood pressure
aminoopeptidase
specific
Prior art date
Application number
AT99900531T
Other languages
English (en)
Inventor
Catherine Llorens-Cortes
Pierre Corvol
Marie-Claude Fournie-Zaluski
Bernard Roques
Original Assignee
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Centre Nat Rech Scient filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE518533T1 publication Critical patent/ATE518533T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99900531T 1998-01-16 1999-01-14 Pharmazeutische zusammensetzung, die einen spezifischen aminopeptidase-a inhibitor enthält, insbesondere ec33, zur senkung des blutdrucks ATE518533T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800453A FR2773712B1 (fr) 1998-01-16 1998-01-16 Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
PCT/FR1999/000059 WO1999036066A1 (fr) 1998-01-16 1999-01-14 Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a

Publications (1)

Publication Number Publication Date
ATE518533T1 true ATE518533T1 (de) 2011-08-15

Family

ID=9521866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900531T ATE518533T1 (de) 1998-01-16 1999-01-14 Pharmazeutische zusammensetzung, die einen spezifischen aminopeptidase-a inhibitor enthält, insbesondere ec33, zur senkung des blutdrucks

Country Status (10)

Country Link
US (1) US6340708B1 (de)
EP (1) EP1047413B1 (de)
AT (1) ATE518533T1 (de)
CA (1) CA2318348C (de)
CY (1) CY1111905T1 (de)
DK (1) DK1047413T3 (de)
ES (1) ES2367568T3 (de)
FR (1) FR2773712B1 (de)
PT (1) PT1047413E (de)
WO (1) WO1999036066A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
ATE400552T1 (de) * 2002-07-16 2008-07-15 Inst Nat Sante Rech Med 4,4' -dithiobis- (3-aminobutane-1-sulfonate)- derivate und sie enthaltende zusammensetzungen
FR2852597A1 (fr) * 2003-03-20 2004-09-24 Inst Nat Sante Rech Med Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
HUE033403T2 (en) * 2011-12-21 2017-11-28 Quantum Genomics Combination with (3S, 3S ') - 4,4'-disulfandyl-bis (3-aminobutane-1-sulfonic acid) and a second antihypertensive agent
EP2893925A1 (de) 2014-01-09 2015-07-15 Attoquant Diagnostics GmbH Zusammensetzungen und Verfahren zur Behandlung von Erkrankungen im Zusammenhang mit dem Renin-Angiotensin-System
EP3650020A1 (de) 2013-12-11 2020-05-13 Alterras Therapeutics GmbH Zusammensetzungen und verfahren zur behandlung von erkrankungen im zusammenhang mit dem renin-angiotensin-system
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
CN113166180A (zh) 2018-10-26 2021-07-23 量子基因公司 新的氨基次膦衍生物作为氨肽酶a抑制剂
TW202029962A (zh) * 2018-10-26 2020-08-16 法商量子基因科技有限公司 胺肽酶a抑制劑及包含其的醫藥組合物
TW202100146A (zh) 2019-03-11 2021-01-01 法商量子基因科技有限公司 用於治療高血壓或心衰竭的化合物及包含其之組成物

Also Published As

Publication number Publication date
US6340708B1 (en) 2002-01-22
CA2318348C (fr) 2010-11-02
EP1047413A1 (de) 2000-11-02
EP1047413B1 (de) 2011-08-03
CA2318348A1 (fr) 1999-07-22
FR2773712B1 (fr) 2000-06-02
ES2367568T3 (es) 2011-11-04
PT1047413E (pt) 2011-10-13
DK1047413T3 (da) 2011-10-31
CY1111905T1 (el) 2015-11-04
WO1999036066A1 (fr) 1999-07-22
FR2773712A1 (fr) 1999-07-23

Similar Documents

Publication Publication Date Title
CY1111905T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα εναν επιλεκτικο αναστολεα της αμινοπεπτιδασης α, ειδικα τον ec33, για τη μειωση της αρτηριακης πιεσεως
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
BR9913742A (pt) Inibidores de fator viia
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
NO972538D0 (no) Nye sulfonamider
HN2002000152A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco
CR7074A (es) Derivados de mercaptoacetylamida y proceso para su preparacion y uso
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
AR109263A2 (es) Composición que comprende moxidectina
CL2004000366A1 (es) USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
CU23043A1 (es) Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BRPI0408299A (pt) inibidores de catepsina s
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
ATE374022T1 (de) Oxaliplatinlösungskonzentrate
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
DK1765342T3 (da) Farmaceutisk sammensætning omfattende amlodipinbesilat og lisinoprildihydrat og fremgangsmåde til fremstilling deraf
MXPA05008572A (es) Uso de dipiridamol en combinacion con acido acetilsalicilico y un antagonista de angiotensina ii para la prevencion de accidente cerebrovascular.
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
UY26930A1 (es) Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso
BRPI0511323A (pt) tetraidroisoquinolinas substituìdas usadas na forma de inibidores de mmp, método para a produção e uso das mesmas na forma de drágeas
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
BR0307039A (pt) Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1047413

Country of ref document: EP